NCT03614949 2025-12-19
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Active not recruiting
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Case Comprehensive Cancer Center